Table 2.
Average health costs and public transfer income (measured as weeks) for the TKR plus non-surgical treatment group and the non-surgical treatment group prior to the study, at year 1 and year 2 follow-up
| Health costs | Pre-period | Year 1 (0–12 months) | Year 2 (12–24 months) | ||||||
| TKR +non-surgical (n=50) |
Non-surgical (n=50) | P value | TKR +non-surgical (n=50) |
Non-surgical (n=50) |
P value | TKR +non-surgical (n=50) |
Non-surgical (n=50) |
P value | |
| € | € | € | € | € | € | ||||
| Hospital sector inpatient (incl. TKRs) | 515 | 546 | 1.000 | 13 149 | 4016 | <0.001* | 3845 | 3881 | 1.000 |
| Inpatient (excl. TKRs) | 515 | 546 | 1.000 | 3412 | 1515 | 0.980 | 3436 | 2278 | 1.000 |
| Outpatient | 1132 | 1234 | 1.000 | 2035 | 2188 | 1.000 | 1887 | 2772 | 1.000 |
| Primary sector, all | 448 | 421 | 1.000 | 454 | 351 | 0.550 | 382 | 361 | 1.000 |
| General practitioner | 270 | 238 | 1.000 | 325 | 193 | 0.010* | 246 | 201 | 0.900 |
| Medical specialist | 126 | 122 | 1.000 | 84 | 91 | 1.000 | 91 | 90 | 1.000 |
| Physiotherapy | 37 | 42 | 1.000 | 24 | 45 | 0.980 | 25 | 44 | 1.000 |
| Chiropractic | 3 | 5 | 1.000 | 5 | 5 | 1.000 | 6 | 3 | 1.000 |
| Laboratory work and other | 12 | 14 | 1.000 | 17 | 18 | 1.000 | 15 | 24 | 1.000 |
| Prescription medication, all | 599 | 443 | 1.000 | 704 | 472 | 0.950 | 620 | 471 | 1.000 |
| Other medication | 534 | 377 | 1.000 | 607 | 382 | 0.920 | 572 | 403 | 1.000 |
| Pain medication | 65 | 66 | 1.000 | 97 | 91 | 1.000 | 48 | 69 | 1.000 |
| NSAID (N02B+M01A) | 51 | 50 | 1.000 | 53 | 66 | 1.000 | 33 | 52 | 0.980 |
| Opioids (N02A) | 13 | 13 | 1.000 | 45 | 21 | 0.250 | 14 | 14 | 1.000 |
| All health costs (incl. TKRs) | 2695 | 2644 | 1.000 | 16 343 | 7028 | <0.001* | 6733 | 7486 | 1.000 |
| All health costs (excl. TKRs) | 2695 | 2644 | 1.000 | 6606 | 4527 | 1.000 | 6325 | 5882 | 1.000 |
excl., excluding; incl., including; NSAID, non-steroidal anti-inflammatory drug; TKR, total knee replacement.